Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 03:51PM ET
65.76
Dollar change
+1.10
Percentage change
1.70
%
IndexRUT P/E- EPS (ttm)-5.19 Insider Own25.76% Shs Outstand31.84M Perf Week-4.72%
Market Cap2.37B Forward P/E- EPS next Y-5.51 Insider Trans-0.43% Shs Float26.71M Perf Month-3.39%
Income-152.99M PEG- EPS next Q-1.33 Inst Own70.39% Short Float7.20% Perf Quarter62.57%
Sales0.15M P/S15773.63 EPS this Y-1.34% Inst Trans2.79% Short Ratio4.25 Perf Half Y105.24%
Book/sh10.43 P/B6.30 EPS next Y-4.48% ROA-45.21% Short Interest1.92M Perf Year58.23%
Cash/sh9.20 P/C7.14 EPS next 5Y- ROE-50.19% 52W Range27.02 - 73.00 Perf YTD65.39%
Dividend Est.- P/FCF- EPS past 5Y-111.11% ROI-44.26% 52W High-9.92% Beta1.27
Dividend TTM- Quick Ratio14.25 Sales past 5Y-40.00% Gross Margin-1245.70% 52W Low143.38% ATR (14)3.61
Dividend Ex-Date- Current Ratio14.25 EPS Y/Y TTM-25.19% Oper. Margin-112543.71% RSI (14)52.44 Volatility5.65% 5.56%
Employees136 Debt/Eq0.04 Sales Y/Y TTM-99.96% Profit Margin-101319.21% Recom1.00 Target Price88.00
Option/ShortYes / Yes LT Debt/Eq0.04 EPS Q/Q-22.83% Payout- Rel Volume0.33 Prev Close64.66
Sales Surprise- EPS Surprise2.49% Sales Q/Q- EarningsFeb 28 AMC Avg Volume452.74K Price65.76
SMA20-1.77% SMA507.46% SMA20055.86% Trades Volume144,554 Change1.70%
Date Action Analyst Rating Change Price Target Change
Feb-21-24Initiated William Blair Outperform
Dec-08-23Initiated Wells Fargo Overweight $60
Jul-31-23Initiated Wedbush Outperform $86
Jul-26-23Initiated BofA Securities Buy $65
Feb-14-23Initiated Cowen Outperform
Oct-18-22Initiated Truist Buy $100
Jul-26-22Initiated BTIG Research Buy $80
Dec-08-20Reiterated H.C. Wainwright Buy $50 → $100
May-04-20Initiated SVB Leerink Outperform $42
May-04-20Initiated Piper Sandler Overweight $35
Mar-14-24 08:00AM
Mar-05-24 08:00AM
Feb-28-24 04:42PM
04:01PM
08:50AM
09:55AM Loading…
Feb-21-24 09:55AM
Feb-12-24 08:50AM
Jan-31-24 09:55AM
Jan-29-24 08:00AM
Jan-24-24 08:50AM
Jan-23-24 09:55AM
Jan-15-24 09:55AM
Jan-09-24 08:00AM
Jan-03-24 09:29PM
04:05PM
08:00AM Loading…
08:00AM
Dec-15-23 06:39PM
Dec-11-23 06:00AM
Nov-07-23 08:00AM
Nov-06-23 08:00AM
Nov-02-23 09:00AM
Oct-04-23 08:00AM
Sep-05-23 08:00AM
Aug-07-23 08:00AM
Jul-31-23 09:51AM
Jul-27-23 04:01PM
Jul-24-23 08:00AM
Jul-04-23 09:39AM
Jun-12-23 08:00AM
Jun-09-23 10:55AM
06:00AM Loading…
06:00AM
Jun-07-23 08:00AM
May-22-23 09:00AM
May-11-23 04:01PM
May-04-23 04:01PM
May-01-23 12:00PM
Apr-21-23 01:55PM
Apr-19-23 08:00AM
Mar-03-23 04:01PM
Mar-02-23 08:38AM
Mar-01-23 08:00AM
Feb-07-23 08:00AM
Jan-25-23 06:16AM
Dec-23-22 12:00PM
Dec-12-22 10:00AM
Nov-24-22 09:55AM
Nov-22-22 08:00AM
Nov-08-22 12:00PM
09:55AM
Nov-07-22 04:01PM
Nov-03-22 09:00AM
07:00AM
Oct-17-22 12:56PM
Oct-14-22 07:38PM
Sep-12-22 06:00AM
Sep-06-22 08:00AM
08:00AM
Aug-18-22 06:30AM
Aug-04-22 04:01PM
Jul-20-22 09:26AM
Jun-13-22 08:00AM
Jun-10-22 06:00AM
May-18-22 12:38PM
12:25PM
06:00AM
May-17-22 04:01PM
May-12-22 04:01PM
May-10-22 12:10PM
May-05-22 08:00AM
Mar-09-22 04:01PM
Feb-11-22 08:00AM
Jan-31-22 08:00AM
Dec-28-21 09:38AM
Dec-21-21 09:38AM
Dec-16-21 09:38AM
Dec-13-21 04:05PM
09:01AM
08:00AM
Dec-08-21 09:38AM
Nov-22-21 08:00AM
Nov-19-21 07:40AM
Nov-15-21 08:00AM
Nov-11-21 08:00AM
Nov-08-21 08:00AM
Nov-04-21 09:01AM
09:00AM
Oct-06-21 11:31AM
Oct-04-21 08:00AM
Sep-02-21 08:00AM
Aug-05-21 04:01PM
Aug-02-21 09:00AM
Jul-07-21 04:24AM
Jun-22-21 04:01PM
Jun-11-21 08:00AM
May-27-21 08:00AM
May-25-21 08:00AM
May-14-21 08:00AM
May-12-21 04:01PM
May-06-21 04:01PM
Apr-08-21 03:20AM
Keros Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It focuses on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with unmet medical need. The company was founded in 2015 and is headquartered in Lexington, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Regnante KeithChief Financial OfficerNov 04 '23Option Exercise16.0040,000640,00040,000Jan 08 04:43 PM
Regnante KeithChief Financial OfficerNov 04 '23Sale45.2940,0001,811,6000Jan 08 04:43 PM
Regnante KeithChief Financial OfficerJun 09 '23Option Exercise16.0020,000320,00020,000Jun 12 04:13 PM
Regnante KeithChief Financial OfficerJun 09 '23Sale45.4220,000908,3670Jun 12 04:13 PM
Regnante KeithChief Financial OfficerJun 08 '23Option Exercise16.0020,000320,00020,000Jun 12 04:13 PM
Regnante KeithChief Financial OfficerJun 08 '23Sale47.7920,000955,8720Jun 12 04:13 PM
Seehra JasbirChief Executive OfficerApr 08 '23Option Exercise0.484,0001,920252,856Apr 11 04:05 PM